CD40 distribution and patterns of expression were further explored in larger cohorts of non-small cell lung cancer (NSCLC), ovarian cancer, and pancreatic adenocarcinoma, and correlated with clinicopathologic characteristics and outcome. Here, CD40 is linked to pancreatic adenocarcinoma.